{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:35:21Z","timestamp":1788543321566,"version":"build-2803163510"},"reference-count":84,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"publisher","award":["DS460"],"award-info":[{"award-number":["DS460"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>AL (light-chain) amyloidosis is a systemic disease in which amyloid fibers are formed from kappa or lambda immunoglobulin light chains, or fragments thereof, produced by a neoplastic clone of plasmocytes. The produced protein is deposited in tissues and organs in the form of extracellular deposits, which leads to impairment of their functions and, consequently, to death. Despite the development of research on pathogenesis and therapy, the mortality rate of patients with late diagnosed amyloidosis is 30%. The diagnosis is delayed due to the complex clinical picture and the slow progression of the disease. This is the type of amyloidosis that most often contributes to cardiac lesions and causes cardiac amyloidosis (CA). Early diagnosis and correct identification of the type of amyloid plays a crucial role in the planning and effectiveness of therapy. In addition to standard histological studies based on Congo red staining, diagnostics are enriched by tests to determine the degree of cardiac involvement. In this paper, we discuss current diagnostic methods used in cardiac light chain amyloidosis and the latest therapies that contribute to an improved patient prognosis.<\/jats:p>","DOI":"10.3390\/jcm11040911","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T21:22:15Z","timestamp":1644441735000},"page":"911","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis"],"prefix":"10.3390","volume":"11","author":[{"given":"Agnieszka","family":"Stelmach-Go\u0142dy\u015b","sequence":"first","affiliation":[{"name":"Department of Immunology, Faculty of Health Sciences, Jan Kochanowski University, 25-317 Kielce, Poland"},{"name":"Department of Hematology, Holy Cross Cancer Centre, 25-734 Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Zaborek-\u0141yczba","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3420-4832","authenticated-orcid":false,"given":"Jakub","family":"\u0141yczba","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Garus","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Health Sciences, Jan Kochanowski University, 25-317 Kielce, Poland"},{"name":"Department of Hematology, Holy Cross Cancer Centre, 25-734 Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Pasiarski","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Health Sciences, Jan Kochanowski University, 25-317 Kielce, Poland"},{"name":"Department of Hematology, Holy Cross Cancer Centre, 25-734 Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-6659","authenticated-orcid":false,"given":"Paulina","family":"Mertowska","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2430-5020","authenticated-orcid":false,"given":"Paulina","family":"Ma\u0142kowska","sequence":"additional","affiliation":[{"name":"Institute of Biology, University of Szczecin, 71-412 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-6928","authenticated-orcid":false,"given":"Rafa\u0142","family":"Hrynkiewicz","sequence":"additional","affiliation":[{"name":"Institute of Biology, University of Szczecin, 71-412 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4065-3842","authenticated-orcid":false,"given":"Paulina","family":"Nied\u017awiedzka-Rystwej","sequence":"additional","affiliation":[{"name":"Institute of Biology, University of Szczecin, 71-412 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-4741","authenticated-orcid":false,"given":"Ewelina","family":"Grywalska","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac Amyloidosis","volume":"18","author":"Hawkins","year":"2018","journal-title":"Clin. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Monsellier, E., Ramazzotti, M., Taddei, N., and Chiti, F. (2008). Aggregation Propensity of the Human Proteome. PLoS Comput. Biol., 4.","DOI":"10.1371\/journal.pcbi.1000199"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","article-title":"Updates in Cardiac Amyloidosis: A Review","volume":"1","author":"Banypersad","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3949\/ccjm.84.s3.02","article-title":"Cardiac Amyloidosis: An Update on Diagnosis and Treatment","volume":"84","author":"Donnelly","year":"2017","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1161\/CIRCULATIONAHA.111.069195","article-title":"Cardiac Amyloidosis","volume":"126","author":"Quarta","year":"2012","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The Amyloid State and Its Association with Protein Misfolding Diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymeth.2004.03.012","article-title":"Techniques to Study Amyloid Fibril Formation in Vitro","volume":"34","author":"Nilsson","year":"2004","journal-title":"Methods"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic Amyloidosis from A (AA) to T (ATTR): A Review","volume":"289","author":"Muchtar","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature20416","article-title":"The Activities of Amyloids from a Structural Perspective","volume":"539","author":"Riek","year":"2016","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2017.1.1","article-title":"AL Amyloidosis: From Molecular Mechanisms to Targeted Therapies","volume":"2017","author":"Merlini","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular Mechanisms of Amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000495455","article-title":"Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis","volume":"141","author":"Vaxman","year":"2019","journal-title":"Acta Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL Amyloidosis: A Real-World Study Using US Claims Data","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","article-title":"Review: History of the Amyloid Fibril","volume":"130","author":"Sipe","year":"2000","journal-title":"J. Struct. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/PL00000706","article-title":"Immunoglobulin Light Chains, Glycosaminoglycans, and Amyloid","volume":"57","author":"Stevens","year":"2000","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_17","first-page":"349","article-title":"Wolne \u0142a\u0144cuchy lekkie w surowicy-znaczenie diagnostyczne i prognostyczne w dyskrazjach plazmocytowych","volume":"40","author":"Kuliczkowski","year":"2009","journal-title":"Acta Haematol. Pol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2015.03.179","article-title":"SAP: Structure, Function, and Its Roles in Immune-Related Diseases","volume":"187","author":"Xi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"18349","DOI":"10.1073\/pnas.0806270105","article-title":"Molecular Structural Basis for Polymorphism in Alzheimer\u2019s \u03b2-Amyloid Fibrils","volume":"105","author":"Paravastu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/ajh.25149","article-title":"Immunoglobulin Light Chain Amyloidosis: 2018 Update on Diagnosis, Prognosis, and Treatment","volume":"93","author":"Gertz","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100334","DOI":"10.1016\/j.jbc.2021.100334","article-title":"Molecular Mechanism of Amyloidogenic Mutations in Hypervariable Regions of Antibody Light Chains","volume":"296","author":"Rottenaicher","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_22","first-page":"65","article-title":"Amyloidosis: Its Nature and Pathogenesis","volume":"10","author":"Glenner","year":"1973","journal-title":"Semin. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI110635","article-title":"Bence Jones Proteins and Light Chains of Immunoglobulins. Preferential Association of the V Lambda VI Subgroup of Human Light Chains with Amyloidosis AL (Lambda)","volume":"70","author":"Solomon","year":"1982","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2141.2002.03438.x","article-title":"Translocations of 14q32 and Deletions of 13q14 Are Common Chromosomal Abnormalities in Systemic Amyloidosis","volume":"117","author":"Harrison","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood-2007-11-122101","article-title":"Evaluation of the Cytogenetic Aberration Pattern in Amyloid Light Chain Amyloidosis as Compared with Monoclonal Gammopathy of Undetermined Significance Reveals Common Pathways of Karyotypic Instability","volume":"111","author":"Bochtler","year":"2008","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood.V98.7.2266","article-title":"Translocations Involving the Immunoglobulin Heavy-Chain Locus Are Possible Early Genetic Events in Patients with Primary Systemic Amyloidosis","volume":"98","author":"Hayman","year":"2001","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2009-04-202879","article-title":"How I Treat Amyloidosis","volume":"114","author":"Comenzo","year":"2009","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and Natural History of Primary Systemic Amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443200","article-title":"Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy","volume":"135","author":"Muchtar","year":"2016","journal-title":"Acta Haematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.57.121304.131243","article-title":"Amyloidosis","volume":"57","author":"Pepys","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The Amyloid Hypothesis of Alzheimer\u2019s Disease at 25 Years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"19813","DOI":"10.1074\/jbc.M116.736736","article-title":"Cell Damage in Light Chain Amyloidosis","volume":"291","author":"Lin","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2011-05-355784","article-title":"The Repertoire of \u03bb Light Chains Causing Predominant Amyloid Heart Involvement and Identification of a Preferentially Involved Germline Gene, IGLV1-44","volume":"119","author":"Perfetti","year":"2012","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2016-10-743997","article-title":"Clarifying Immunoglobulin Gene Usage in Systemic and Localized Immunoglobulin Light-Chain Amyloidosis by Mass Spectrometry","volume":"129","author":"Kourelis","year":"2017","journal-title":"Blood"},{"key":"ref_35","first-page":"644","article-title":"Treatment of Primary Systemic Amyloidosis (AL): Role of Intensive and Standard Therapy","volume":"10","author":"Sher","year":"2012","journal-title":"Clin. Adv. Hematol. Oncol. HO"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2169\/internalmedicine.9206-17","article-title":"Nationwide Survey of 741 Patients with Systemic Amyloid Light-Chain Amyloidosis in Japan","volume":"57","author":"Shimazaki","year":"2018","journal-title":"Intern. Med. Tokyo Jpn."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/01913123.2017.1349852","article-title":"Contribution of Human Smooth Muscle Cells to Amyloid Angiopathy in AL (Light-Chain) Amyloidosis","volume":"41","author":"Vora","year":"2017","journal-title":"Ultrastruct. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The Systemic Amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/labinvest.3700161","article-title":"AL-Amyloidosis and Light-Chain Deposition Disease Light Chains Induce Divergent Phenotypic Transformations of Human Mesangial Cells","volume":"84","author":"Keeling","year":"2004","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Perkowska-Ptasinska, A., Deborska-Materkowska, D., Bartczak, A., Stompor, T., Liberek, T., Bullo-Piontecka, B., Wasinska, A., Serwacka, A., Klinger, M., and Chyl, J. (2016). Kidney Disease in the Elderly: Biopsy Based Data from 14 Renal Centers in Poland. BMC Nephrol., 17.","DOI":"10.1186\/s12882-016-0410-8"},{"key":"ref_41","first-page":"2279","article-title":"Renal Amyloidosis Complicated by Light Chain Deposition Nephropathy: A Case Report","volume":"12","author":"Yu","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_42","first-page":"3132","article-title":"Clinical Outcome of Immunoglobulin Light Chain Amyloidosis Affecting the Kidney","volume":"24","author":"Gertz","year":"2009","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/ndt\/gfy291","article-title":"AL Amyloidosis: Advances in Diagnostics and Treatment","volume":"34","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ajh.24738","article-title":"Renal Outcomes in Patients with AL Amyloidosis: Prognostic Factors, Renal Response and the Impact of Therapy","volume":"92","author":"Kastritis","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2141.2000.02183.x","article-title":"Bleeding Symptoms and Coagulation Abnormalities in 337 Patients with AL-Amyloidosis","volume":"110","author":"Mumford","year":"2000","journal-title":"Br. J. Haematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","article-title":"Cardiac Amyloidosis: Pathology, Nomenclature, and Typing","volume":"24","author":"Maleszewski","year":"2015","journal-title":"Cardiovasc. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ahj.2003.09.020","article-title":"Endomyocardial Biopsy Plays a Role in Diagnosing Patients with Unexplained Cardiomyopathy","volume":"147","author":"Ardehali","year":"2004","journal-title":"Am. Heart J."},{"key":"ref_48","first-page":"479","article-title":"Amyloidosis of Epicardial and Intramural Coronary Arteries as an Unusual Cause of Myocardial Infarction and Refractory Angina Pectoris","volume":"3","author":"Miani","year":"2002","journal-title":"Ital. Heart J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"H544","DOI":"10.1152\/ajpheart.00815.2011","article-title":"Current Perspectives on Cardiac Amyloidosis","volume":"302","author":"Guan","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cpcardiol.2012.11.002","article-title":"Current Trends in Diagnosis and Management of Cardiac Amyloidosis","volume":"38","author":"Esplin","year":"2013","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The Clinical Features of Immunoglobulin Light-Chain (AL) Amyloidosis with Heart Involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"QJM Mon. J. Assoc. Physicians"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and Management of the Cardiac Amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1378\/chest.124.3.969","article-title":"Persistent Pleural Effusions in Primary Systemic Amyloidosis: Etiology and Prognosis","volume":"124","author":"Berk","year":"2003","journal-title":"Chest"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0002-9149(02)02277-4","article-title":"Usefulness of Pulsed Tissue Doppler Imaging for Evaluating Systolic and Diastolic Left Ventricular Function in Patients with AL (Primary) Amyloidosis","volume":"89","author":"Koyama","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12471-019-1299-1","article-title":"Cardiac Amyloidosis: The Need for Early Diagnosis","volume":"27","author":"Oerlemans","year":"2019","journal-title":"Neth. Heart J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00277-009-0857-9","article-title":"Amyloid in Bone Marrow Smears of Patients Affected by Multiple Myeloma","volume":"89","author":"Petruzziello","year":"2010","journal-title":"Ann. Hematol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.humpath.2017.11.001","article-title":"Abdominal Fat Pad Excisional Biopsy for the Diagnosis and Typing of Systemic Amyloidosis","volume":"72","author":"Garcia","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5858\/134.4.545","article-title":"Amyloidosis-Where Are We Now and Where Are We Heading?","volume":"134","author":"Picken","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ki.2014.333","article-title":"The Use of Immunoglobulin Light Chain Assays in the Diagnosis of Paraprotein-Related Kidney Disease","volume":"87","author":"Yadav","year":"2015","journal-title":"Kidney Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clin. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2013.50.8499","article-title":"Coexistent Multiple Myeloma or Increased Bone Marrow Plasma Cells Define Equally High-Risk Populations in Patients with Immunoglobulin Light Chain Amyloidosis","volume":"31","author":"Kourelis","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1182\/blood-2010-06-290668","article-title":"Serum Immunoglobulin Free Light-Chain Measurement in Primary Amyloidosis: Prognostic Value and Correlations with Clinical Features","volume":"116","author":"Kumar","year":"2010","journal-title":"Blood"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood-2005-07-2922","article-title":"Absolute Values of Immunoglobulin Free Light Chains Are Prognostic in Patients with Primary Systemic Amyloidosis Undergoing Peripheral Blood Stem Cell Transplantation","volume":"107","author":"Dispenzieri","year":"2006","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and Treatment of Cardiac Amyloidosis: A Position Statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Rapezzi","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-Terminal pro-Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1182\/blood-2005-11-4385","article-title":"Circulating Amyloidogenic Free Light Chains and Serum N-Terminal Natriuretic Peptide Type B Decrease Simultaneously in Association with Improvement of Survival in AL","volume":"107","author":"Palladini","year":"2006","journal-title":"Blood"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum Cardiac Troponins and N-Terminal pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.echo.2013.12.010","article-title":"Advanced Cardiac Amyloidosis Associated with Normal Interventricular Septal Thickness: An Uncommon Presentation of Infiltrative Cardiomyopathy","volume":"27","author":"Suresh","year":"2014","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.mayocp.2014.01.013","article-title":"Cardiac Amyloidosis without Increased Left Ventricular Wall Thickness","volume":"89","author":"Lee","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.echo.2010.03.027","article-title":"Independent Predictors of Survival in Primary Systemic (Al) Amyloidosis, Including Cardiac Biomarkers and Left Ventricular Strain Imaging: An Observational Cohort Study","volume":"23","author":"Bellavia","year":"2010","journal-title":"J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic Cardiac Amyloidoses","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic Implantation of Cardioverter-Defibrillator in Patients with Severe Cardiac Amyloidosis and High Risk for Sudden Cardiac Death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood-2006-07-035352","article-title":"Safety and Efficacy of Risk-Adapted Cyclophosphamide, Thalidomide, and Dexamethasone in Systemic AL Amyloidosis","volume":"109","author":"Wechalekar","year":"2007","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2004-05-1924","article-title":"Clinical Efficacy of High-Dose Dexamethasone with Maintenance Dexamethasone\/Alpha Interferon in Patients with Primary Systemic Amyloidosis: Results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628","volume":"104","author":"Dhodapkar","year":"2004","journal-title":"Blood"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1182\/blood.V116.21.3992.3992","article-title":"Assessing Proteostasis and Proteasome Stress In Light Chain Amyloidosis","volume":"116","author":"Oliva","year":"2010","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V116.21.3063.3063","article-title":"The Combination of Cyclophosphamide-Bortezomib-Dexamethasone (CYBOR-D) Is a Highly Effective and Well Tolerated Regimen That Produces Rapid and Complete Hematological Response In Patients with AL Amyloidosis","volume":"116","author":"Mikhael","year":"2010","journal-title":"Blood"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1182\/blood.V114.22.746.746","article-title":"Melphalan and Dexamethasone Plus Bortezomib Induces Hematologic and Organ Responses in AL-Amyloidosis with Tolerable Neurotoxicity","volume":"114","author":"Zonder","year":"2009","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1200\/JCO.2015.62.4015","article-title":"Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study","volume":"33","author":"Dispenzieri","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10428194.2018.1485914","article-title":"Daratumumab for the Treatment of AL Amyloidosis","volume":"60","author":"Sidiqi","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"100065","DOI":"10.1016\/j.esmoop.2021.100065","article-title":"First-Line Daratumumab Shows High Efficacy and Tolerability Even in Advanced AL Amyloidosis: The Real-World Experience","volume":"6","author":"Jeryczynski","year":"2021","journal-title":"ESMO Open"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2016-06-722496","article-title":"First Report of Safety and Efficacy of Daratumumab in 2 Cases of Advanced Immunoglobulin Light Chain Amyloidosis","volume":"128","author":"Sher","year":"2016","journal-title":"Blood"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/4\/911\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:17:04Z","timestamp":1760134624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/4\/911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":84,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["jcm11040911"],"URL":"https:\/\/doi.org\/10.3390\/jcm11040911","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]}}}